Objective To estimate the resource use of patients with obstructive hypertrophic cardiomyopathy (HCM), stratified by New York Heart Association (NYHA) class, in the English and Northern Irish ...

Your provider will first use the ACC/AHA classification model to diagnose which stage of HF you're experiencing. The NYHA system gets added later on if you are in the later stages of the ACC/AHA ...

A gene therapy for heart failure being developed by Bayer’s AskBio unit has been granted fast-track status by the FDA, shortly after it showed preliminary signs of efficacy in a phase 1 trial.

The following is a summary of “Effect of disopyramide therapy on functional capacity improvement in patients with obstructive ...

Cardiopulmonary evaluation included assessment of New York Heart Association (NYHA) functional class, left ventricular ejection fraction, peak oxygen uptake, and the distance covered during a ...

congestive heart failure New York Heart Association (NYHA) class II or greater, unstable angina, documented myocardial infarction or stroke (transient ischaemic attack) within 6 months preceding ...

[70] recently reported on switching between β blockers (metoprolol and carvedilol) in 68 patients treated with either agent for 1 year who had improved in terms of LVEF and NYHA class. Patients ...

Proceeded with SRT: 3.6% vs. 3.6% Guideline eligible for SRT but did not proceed: 14.3% vs. 69.6% Secondary outcomes for mavacamten vs. placebo: Improvement in NYHA class ≥I class: 63% vs. 21% (p < ...

A new study published in the Journal of American Medical Association showed that individuals with heart failure with ...

The study investigated associations between 3D-VCA values and one-year mortality, alongside secondary outcomes like New York Heart Association (NYHA) classification and major adverse events. Patients ...

but they did show improvements in secondary endpoints for maximal oxygen consumption and NYHA heart failure class.